Reference 2018-347

REF:           2018-347

Subject:       Joint Hypermobility Prevalence



I am currently undertaking a report into the prevalence of joint hypermobility within the general population, and was curious as to if you had any information on the following:

– The average age of those receiving treatment for Joint Hypermobility Syndrome.

– The comparative percentage of males and females receiving treatment for Joint Hypermobility Syndrome

– The number of males receiving treatment for joint hypermobility at ages: 8, 9, 10, 11-12, 12-13, 13-14, 15-1


We do not hold this information.